1 / 3
30 likes | 89 Views
The global genome Editing market is expected to grow at a CAGR of more than 14.0% between 2015 and 2023. The global genome Editing market is estimated to cross US$ 7.0 billion by the end of 2023.
E N D
Genome Editing Market is Determined to Cross US$ 7.0 Billion By2023 New York, August 25, 2018: Market Research Engine has published a new report titledas “Global Genome Editing Market Analysis by Application, Technology and EndUser – Forecast 2015 to 2021”. The global genome Editing market is expected to grow at a CAGR of more than 14.0% between 2015 and 2023. The global genome Editing market is estimated to cross US$ 7.0 billion by the end of2023. The global genome editing market is rapidly increasing due to the increased government funding for genomics technology, rise in the production of genetically modified crops and technological advancements these all factors are driving the growth of thismarket. Recent developments across genome editing technologies have resulted in the creation of next generation nucleases that have higher levels of accuracy when correcting genetic mutations and defects. The classes under the genome editing technologies are the 4 broad families of nucleases: ZFNs, TALENs, CRISPR/Cas9, andMeganucleases. Browse Full Report: https://www.marketresearchengine.com/upcommingreport/global-genome- editing-market-analysis-by-application-technology-and-end-user--forecast-2015- to-2021 This market research report categorizes the genome editing marketinto the following segments: The Genome Editing Market is Segmented on the lines of Technology, Application, End User and Geographical Region. By Technology this market is segmented on the basis of CRISPR/CAS9, TALENs, ZFNs, Antisense Technology and Other Technologies. By Application this market is segmented on the basis of Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering and OtherApplications. By End User this market is segmented on the basis of Biotechnology and Pharmaceutical Companies sector, Government and Academic Research Institutes sector and Other Research Organizations sectors. By Geographical Region this market is segmented on the basis of North America, Europe, Asia and Rest of theWorld. Gene editing technologies have an impact across multiple applications areas including plant and animal genetic engineering. However, the area of most disruption is across human cell line engineering, which enables the development of next generation’s therapies and drugs. However, the agricultural industry has seen more success with gene editing techniques largely due to the less stringent regulatory environment. Request Sample Report: https://www.marketresearchengine.com/upcommingreport/global-genome-
editing-market-analysis-by-application-technology-and-end-user--forecast-2015- to-2021 • Table ofContents • INTRODUCTION • ResearchMethodology • ExecutiveSummary • PremiumInsights • MarketOverview • Global Genome Editing/Engineering Market, ByTechnology • Global Genome Editing/Genome Engineering Market, By Application 8 Global Genome Editing/Engineering Market, By EndUser • 9 Genome Editing/Genome Engineering Market, By Region 10 CompetitiveLandscape • CompanyProfiles • Thermo Fisher Scientific, Inc. • MerckKGaA • Horizon Discovery GroupPLC • Genscript USAInc. • Sangamo Biosciences,Inc. • Integrated DNA Technologies,Inc. • Lonza GroupLtd. • New England Biolabs,Inc. • Origene Technologies,Inc. • Transposagen Biopharmaceuticals, Inc. MediaContact Company Name: Market ResearchEngine
Contact Person: John Bay Email:john@marketresearchengine.com Phone: +1-855-984-1862 Country: UnitedStates Website:https://www.marketresearchengine.com/
